Compounds > fluoxetine

fluoxetine and mocetinostat

fluoxetine has been researched along with mocetinostat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraka, AM; El Din, NM; El Said Darwish, I; Guemei, AA1
Jung, HC; Kim, IK; Kim, JM; Kim, JS; Kim, N; Koh, SJ; Song, IS1
Aksu, U; Erman, H; Gelisgen, R; Guner, I; Sahin, A; Sahin, G; Sengezer-Inceli, M; Uzun, D; Uzun, H; Yaman, OM; Yelmen, N1
Aksu, U; Erman, H; Esrefoglu, M; Gelisgen, R; Guner, I; Pala, M; Sahin, G; Tok, OE; Uzun, H; Yaman, OM; Yelmen, N1
Assimon, MM; Brookhart, MA; Flythe, JE1

Other Studies

5 other study(ies) available for fluoxetine and mocetinostat

ArticleYear
Do desipramine [10,11-dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and fluoxetine [N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats?
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:3

    Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Glutathione; Interleukin-1beta; Male; Peroxidase; Rats; Tumor Necrosis Factor-alpha

2008
Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 301, Issue:1

    Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Fluoxetine; Humans; I-kappa B Kinase; Interleukin-8; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Neutrophils; NF-kappa B; Peroxidase; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Signal Transduction; Tumor Necrosis Factor-alpha

2011
Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model.
    Journal of physiology and biochemistry, 2014, Volume: 70, Issue:4

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Drug Evaluation, Preclinical; Fluoxetine; Ischemia; Kidney; Male; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats, Sprague-Dawley; Reperfusion Injury

2014
Remote myocardial injury: the protective role of fluoxetine.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:4

    Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Creatine Kinase; Cytokines; Fluoxetine; Hemodynamics; Iron; Lipid Peroxides; Myocardium; Oxidants; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats, Sprague-Dawley; Reperfusion Injury; Thiobarbituric Acid Reactive Substances

2018
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:4

    Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

2019